Brian Foresi, MD, MBA

surgery PGY-1 @ubsurgery • Interested in vascular • Medical Innovation • 🏳️‍🌈

[Department of Surgery | University at Buffalo @UBSurgery]

The more matches the merrier! Congratulations to our PGY-4 Residents, Drs. Lan Le and Ali Awan on their vascular surgery fellowship matches! 🎉

[Department of Surgery | University at Buffalo @UBSurgery]

We can't wait for our newly matched vascular surgery fellows to start in 2027! Congratulations! 🦬

[UMassVascular @UMassVascSurg]

“In 2021, vascular surgeons produced an average of $1.6 million per full-time equivalent, ranking as the fourth-highest revenue-producing specialty in the health care system.” And that is for the obvious, billable services, not for everything else…. https://t.co/JLThmShti8

[Justin B. Dimick @jdimick1]

The framing for this has always seemed strange to me.

Surgery has a 0% failure rate at preventing recurrent appendicitis (yes if done well) and antibiotics a 44% failure rate.

Unless surgery is strongly contraindicated, appendectomy seems like the right choice.

[Anthony DiGiorgio, DO, MHA @DrDiGiorgio]

Primary care doctors being happy about specialists getting a pay cut is why doctors are so ineffective.

We would rather settle grudges than work together.

If I wanted to keep doctors perpetually at each others' throats, I'd design a system exactly like the RBRVS.

[Simon Maechling @simonmaechling]

Now that everyone is an expert on curing pancreatic cancer in mice, not rats - I want to add some context that goes beyond the headline.
You will want to read this.

Cancer is cured in mice all the time.
Thousands of times. ~90% of those “cures” fail in humans.

Why?
Because mice are:
Genetically simpler.
Treated earlier.
Short-lived.
Not humans.

Mice are a filter - not a finish line.

Yes, this study matters. It comes from the Spanish National Cancer Research Centre.

Yes, it’s pancreatic cancer - one of the deadliest there is. Yes, full tumor regression is impressive.

But here’s what it actually means:
“This approach is now good enough to risk years, trials, and millions of euros on.”
Not:
“Cancer is solved.”

What happens next?
More animal work.
Toxicology.
Phase I (safety).
Phase II (maybe works).
Phase III (beats standard care?).

Maybe 8-10 years if everything goes right.

The real damage isn’t failed drugs.
It’s failed expectations.

Every “cured cancer in mice” headline trains the public to believe:
Cures are being hidden.
Progress should be fast.
Scientists are lying when reality hits.

That’s how trust erodes.

Bottom line:
This is how real cancer progress looks.
Messy. Slow. Risky. Incremental.

Not miracles.
Not conspiracies.
Just science - doing the hard work.

[John Mandrola, MD @drjohnm]

My Neutral Martian take of the CREST 2 trial of asymptomatic carotid vascular disease. On @Sensible__Med

Yet another medical reversal. Wow.

https://t.co/PSPg3nRlL0

[NEJM @NEJM]

Presented at #SVIN25:

CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: https://t.co/ojge1CjqiU

Editorial: Managing Asymptomatic Carotid Stenosis https://t.co/D9LH89Edyk

@svinsociety

[Brian Foresi, MD, MBA @Brian2405]

@ShofnerWhitney Penetrating atherosclerotic ulcer (PAU)

[Department of Surgery | University at Buffalo @UBSurgery]

Happy Match Day! 💙🩺 Welcome to our incoming class of interns! We're so happy to have you!

[Journal of Neurosurgery @TheJNS]

#OnlineFirst: Tubular single-port endoscope-assisted surgery for fetal myelomeningocele repair.
https://t.co/gSUigMKcAO

[NEJM @NEJM]

In patients with subdural hematoma and an indication for surgical evacuation, middle meningeal artery embolization plus surgery led to a lower risk of reoperation for recurrence or progression within 90 days than surgery alone. Full EMBOLISE trial results: https://t.co/oNVFLwCmwE

[Brian Foresi, MD, MBA @Brian2405]

@drjoshabecassis @UofLNeurosurg @uofl I would be interested in applying. Let me know how to send the requested documents.

[WalidoNeuroPedia @NeuroWalid]

#neurotip The NASCIS II & III studies showed no clear benefit of steroids in the acute management of spinal cord injury. #neuroscience #spinalcord #neurotrauma

[Women In Neurosurgery (WINS) @WomenInNSGY]

Yesterday we kicked off the morning with the LGBTQIA+WINS Breakfast at #2024CNS! Inspiring discussions on inclusion, diversity, & elevating all voices in #neurosurgery. Together, we’re building a stronger, more inclusive community. #WINSx2024CNS @CNS_Update @pridensgy

[Brian Foresi, MD, MBA @Brian2405]

@CNS_Update is about the people. Had a great time catching up and learning from the best and brightest here in Houston. #neurosurgery #cns2024 #mentorship

[Rushna Ali @RushnaAli6]

Empowering neurosurgeons to be well rounded leaders through CNS Leadership Institute with @nsurgchick as the perfect example of a true leader @CNS_Update #2024CNS @HenryFordNeuro @ASSFNeurosurg @WomenInNSGY

[Brian Hoh, MD, MBA @BrianHoh1]

.@WomenInNSGY President Dr Maryam Rahman, @UFHealth @UFMedicine neurosurgeon, at the podium of General Scientific Session of @CNS_Update Meeting introducing the WINS Trailblazer Award to @grosseaumd #CNS2024

[Khoi Than @KhoiThanMD]

Full house @CNS_Update LGBTQIA+ and @WomenInNSGY breakfast seminar #2024CNS #neurosurgery

[Brian Foresi, MD, MBA @Brian2405]

So excited to finally meet one of my most favorite mentors @DrPannullo @CNS_Update in person she is truly a visionary and happy to be pushing the boundaries of neurosurgery DEI along side her @pridensgy @WomenInNSGY #Neurosurgery #DEI 🏳️‍🌈🧠